Price alert —
Sign in to get a one-time email the moment GRAL crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · GRAL
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.0B | $-0.1B | $-0.1B | $-0.1B | -228.5% | -332.9% |
| 2025-12-31 | $0.0B | $-0.1B | $-0.1B | $-0.1B | -227.5% | -285.4% |
| 2025-09-30 | $0.0B | $-0.1B | $-0.1B | $-0.1B | -245.8% | -346.2% |
| 2025-06-30 | $0.0B | $-0.1B | $-0.1B | $-0.1B | -320.7% | -368.1% |
| 2025-03-31 | $0.0B | $-0.1B | $-0.2B | $-0.1B | -333.6% | -482.5% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare GRAL vs peers
Line GRAL up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with GRAL
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 7 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-05 | -1.37 | -1.96 | +30.1% | +15.3% |
| 2026-02-19 | -2.44 | -2.53 | +3.6% | -50.5% |
| 2025-11-12 | -2.46 | -3.26 | +24.7% | -1.9% |
| 2025-08-12 | -3.18 | -3.56 | +10.8% | +1.1% |
| 2025-05-13 | -3.10 | -3.80 | +18.5% | -23.3% |
| 2025-02-20 | -2.89 | -4.97 | +41.9% | -14.7% |
| 2024-11-12 | -3.50 | -6.43 | +45.5% | +5.5% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAL ★ | $3B | — | -7.5 | 20.0 | -6.5 | 1.2 | 49.3% | 28.1% | — | -3.46% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 50.39%
| Holder | Shares | % out |
|---|---|---|
| Baker Bros. Advisors, LP | 4,028,614 | 9.39% |
| Farallon Capital Management LLC | 3,253,684 | 7.58% |
| Blackrock Inc. | 2,968,536 | 6.92% |
| State Street Corporation | 1,891,893 | 4.41% |
| Primecap Management Company | 1,843,772 | 4.30% |
| Deep Track Capital, Lp | 1,722,797 | 4.01% |
| Sessa Capital IM, L.P. | 1,719,314 | 4.01% |
| Morgan Stanley | 1,632,195 | 3.80% |
| Vanguard Capital Management LLC | 1,527,105 | 3.56% |
| Arbiter Partners Capital Management | 1,034,597 | 2.41% |
Insider activity · 90d
6 buys / 1 sells · ratio 6.0 · Finnhub
- Krevans Sarah BUY 42,628 @ $63.74
- CHASE WILLIAM J BUY 42,702 @ $63.74
- MIZELL STEVEN BUY 42,562 @ $63.74
- SUMME GREGORY L BUY 45,245 @ $63.74
- Partridge Andrew John SELL 163,738 @ $61.08
- Ofman Joshua J. BUY 402,271 @ $61.13
- Ofman Joshua J. BUY 399,117 @ $64.40
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-16 | FORM 4 | view · |
| 4 | 2026-07-16 | FORM 4 | view · |
| 4 | 2026-07-16 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 8-K | 2026-06-22 | 8-K | view · |
| 4 | 2026-06-05 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 8-K | 2026-06-01 | 8-K | view · |
| 10-Q | 2026-05-07 | 10-Q | view · |
| 8-K | 2026-05-05 | 8-K | view · |
| DEF 14A | 2026-04-28 | DEF 14A | view · |
| 4 | 2026-04-17 | FORM 4 | view · |
| 4 | 2026-04-17 | FORM 4 | view · |
| 4 | 2026-04-17 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 10-K | 2026-03-12 | 10-K | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 8-K | 2026-02-19 | 8-K | view · |
| 4 | 2026-01-16 | FORM 4 | view · |
| 4 | 2026-01-16 | FORM 4 | view · |
| 4 | 2026-01-16 | FORM 4 | view · |
| 8-K | 2026-01-12 | 8-K | view · |
| 4 | 2025-12-05 | FORM 4 | view · |
| 4 | 2025-12-05 | FORM 4 | view · |
| 4 | 2025-12-05 | FORM 4 | view · |
| 4 | 2025-11-19 | FORM 4 | view · |
| 4 | 2025-11-18 | Insider transaction (Form 4) | view · |
| 8-K | 2025-11-14 | 8-K | view · |
| 10-Q | 2025-11-13 | 10-Q | view · |
| 8-K | 2025-11-12 | 8-K | view · |
| 8-K | 2025-10-20 | 8-K | view · |
| 4 | 2025-10-16 | FORM 4 | view · |
| 4 | 2025-10-16 | FORM 4 | view · |
| 4 | 2025-10-16 | FORM 4 | view · |
| 4 | 2025-10-16 | FORM 4 | view · |
| 4 | 2025-10-16 | FORM 4 | view · |
| 8-K | 2025-10-16 | 8-K | view · |
| 4 | 2025-10-08 | FORM 4 | view · |
| 4 | 2025-10-03 | FORM 4 | view · |
| 8-K | 2025-09-18 | 8-K | view · |
| 4 | 2025-08-20 | FORM 4 | view · |
| 4 | 2025-08-20 | FORM 4 | view · |
| 10-Q | 2025-08-13 | 10-Q | view · |
| 8-K | 2025-08-12 | 8-K | view · |
| 4 | 2025-07-17 | FORM 4 | view · |
| 4 | 2025-07-17 | FORM 4 | view · |
| 4 | 2025-07-17 | FORM 4 | view · |
| 4 | 2025-07-17 | FORM 4 | view · |
| 4 | 2025-07-03 | FORM 4 | view · |
| 4 | 2025-07-01 | FORM 4 | view · |
About GRAL
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Options picks · GRAL
ITM + OTM ideas from the latest scanLoading…
Congress trades · GRAL
STOCK Act disclosuresLoading…
SEC filings & insiders · GRAL
EDGAR · liveLoading…
Holders · GRAL
Institutions & insider activityLoading…